Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($) $ in Thousands	9 Months Ended
	Sep. 30, 2021	Sep. 30, 2020
Operating activities
Net income	$ 450,096	$ 322,166
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization	246,117	200,807
Amortization of deferred financing costs and debt discount	12,079	9,773
Straight-line rent revenue and other	(208,756)	(161,163)
Share / (Unit)-based compensation expense	38,590	34,600
(Gain) loss from sale of real estate	(8,896)	2,703
Impairment charges		19,006
Straight-line rent and other (recovery) write-off	(1,601)	27,098
Debt refinancing and unutilized financing costs	2,339	611
Pre-acquisition rent collected - Circle Transaction		(35,020)
Tax rate and other changes	42,746	9,661
Other adjustments	15,468	(6,418)
Changes in:
Interest and rent receivables	(19,150)	(6,189)
Other assets	516	12,117
Accounts payable and accrued expenses	25,527	(21,139)
Deferred revenue	(17,588)	33,605
Net cash provided by operating activities	577,487	442,218
Investing activities
Cash paid for acquisitions and other related investments	(4,279,147)	(3,524,910)
Net proceeds from sale of real estate	66,891	93,042
Principal received on loans receivable	1,234,839	738,036
Return of equity investment	11,000	63,122
Capital additions and other investments, net	(253,512)	(116,297)
Net cash used for investing activities	(3,219,929)	(2,747,007)
Financing activities
Proceeds from term debt, net of discount	2,489,735	915,950
Payments of term debt	(689,450)
Revolving credit facilities, net	80,963	225,000
Dividends / Distribution paid	(476,242)	(423,005)
Lease deposits and other obligations to tenants	14,819	7,584
Proceeds from sale of common shares, net of offering costs	1,041,054	294,374
Payment of debt refinancing, deferred financing costs, and other financing activities	(24,245)	(2,143)
Net cash provided by financing activities	2,436,634	1,017,760
Decrease in cash, cash equivalents, and restricted cash for period	(205,808)	(1,287,029)
Effect of exchange rate changes	1,748	9,116
Cash, cash equivalents, and restricted cash at beginning of period	556,369	1,467,991
Cash, cash equivalents, and restricted cash at end of period	352,309	190,078
Interest paid	256,724	231,257
Supplemental schedule of non-cash financing activities:
Dividend / Distributions declared, unpaid	167,231	144,954
Cash, cash equivalents, and restricted cash are comprised of the following:
Cash and cash equivalents at beginning of period	549,884	1,462,286
Restricted cash, included in Other assets at beginning of period	$ 6,485	$ 5,705
Restricted Cash and Cash Equivalents, Asset, Statement of Financial Position [Extensible List]	Other Assets	Other Assets
Cash, cash equivalents, and restricted cash at beginning of period	$ 556,369	$ 1,467,991
Cash and cash equivalents at end of period	349,652	183,794
Restricted cash, included in Other assets at end of period	$ 2,657	$ 6,284
Restricted Cash and Cash Equivalents, Asset, Statement of Financial Position [Extensible List]	Other Assets	Other Assets
Cash, cash equivalents, and restricted cash at end of period	$ 352,309	$ 190,078
MPT Operating Partnership, L.P. [Member]
Operating activities
Net income	450,096	322,166
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization	246,117	200,807
Amortization of deferred financing costs and debt discount	12,079	9,773
Straight-line rent revenue and other	(208,756)	(161,163)
Share / (Unit)-based compensation expense	38,590	34,600
(Gain) loss from sale of real estate	(8,896)	2,703
Impairment charges		19,006
Straight-line rent and other (recovery) write-off	(1,601)	27,098
Debt refinancing and unutilized financing costs	2,339	611
Pre-acquisition rent collected - Circle Transaction		(35,020)
Tax rate and other changes	42,746	9,661
Other adjustments	15,468	(6,418)
Changes in:
Interest and rent receivables	(19,150)	(6,189)
Other assets	516	12,117
Accounts payable and accrued expenses	25,527	(21,139)
Deferred revenue	(17,588)	33,605
Net cash provided by operating activities	577,487	442,218
Investing activities
Cash paid for acquisitions and other related investments	(4,279,147)	(3,524,910)
Net proceeds from sale of real estate	66,891	93,042
Principal received on loans receivable	1,234,839	738,036
Return of equity investment	11,000	63,122
Capital additions and other investments, net	(253,512)	(116,297)
Net cash used for investing activities	(3,219,929)	(2,747,007)
Financing activities
Proceeds from term debt, net of discount	2,489,735	915,950
Payments of term debt	(689,450)
Revolving credit facilities, net	80,963	225,000
Dividends / Distribution paid	(476,242)	(423,005)
Lease deposits and other obligations to tenants	14,819	7,584
Proceeds from sale of units, net of offering costs	1,041,054	294,374
Payment of debt refinancing, deferred financing costs, and other financing activities	(24,245)	(2,143)
Net cash provided by financing activities	2,436,634	1,017,760
Decrease in cash, cash equivalents, and restricted cash for period	(205,808)	(1,287,029)
Effect of exchange rate changes	1,748	9,116
Cash, cash equivalents, and restricted cash at beginning of period	556,369	1,467,991
Cash, cash equivalents, and restricted cash at end of period	352,309	190,078
Interest paid	256,724	231,257
Supplemental schedule of non-cash financing activities:
Dividend / Distributions declared, unpaid	167,231	144,954
Cash, cash equivalents, and restricted cash are comprised of the following:
Cash and cash equivalents at beginning of period	549,884	1,462,286
Restricted cash, included in Other assets at beginning of period	$ 6,485	$ 5,705
Restricted Cash and Cash Equivalents, Asset, Statement of Financial Position [Extensible List]	Other Assets	Other Assets
Cash, cash equivalents, and restricted cash at beginning of period	$ 556,369	$ 1,467,991
Cash and cash equivalents at end of period	349,652	183,794
Restricted cash, included in Other assets at end of period	$ 2,657	$ 6,284
Restricted Cash and Cash Equivalents, Asset, Statement of Financial Position [Extensible List]	Other Assets	Other Assets
Cash, cash equivalents, and restricted cash at end of period	$ 352,309	$ 190,078